| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |